Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for chronic pelvic pain with pelvic floor hypertonicity
NL-OMON48791Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic prostatitis (CP) comparing Botulinum toxin A injection with Placebo saline injection (2 arms). Primary endpoint: Primary pain response. Started Jan 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on NL-OMON48791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48791.